Entries |
Document | Title | Date |
20080234392 | TREHALOSE FATTY ACID ESTER COMPOSITION - Provided is a pigment dispersant having excellent pigment dispersibility thus allowing a larger amount of pigments to be blended in various cosmetics, and capability of imparting good sense of use, make-up lasting, odor, and stability over time to the cosmetic. A trehalose fatty acid ester composition prepared by esterifying trehalose with a fatty acid having 8 to 22 carbon atoms, which has a hydroxyl value of 20 to 500, and the total amount of a diester, a triester, a tetraester and a pentaester in the trehalose fatty acid esters of 10 to 100% by area; and a cosmetic including the trehalose fatty acid ester composition. | 09-25-2008 |
20080249190 | Pesticide Compositions - This invention is related to the field of compositions useful in the control of pests, for example, insects (such as cock-roaches, termites, and ants) and rodents (such as rats and mice), where such compositions comprise soynuts, a non-monosaccharide sugar, and a pesticide. | 10-09-2008 |
20080255249 | Long-Chain Inulin - The invention relates to long-chain inulin and its preparation from artichoke roots, its use in foodstuffs and cosmetic preparations and foodstuffs and cosmetic preparations comprising the long-chain inulin. | 10-16-2008 |
20080262106 | Direct Compressible Trehalose Solids - The present invention relates to direct compressible crystalline or semi-crystalline trehalose solids having a crystal form selected from the group consisting of trehalose dihydrate and mixtures of trehalose dihydrate and anhydrous trehalose, and having a specific surface area of at least 0.25 m | 10-23-2008 |
20080287552 | Process for Obtaining an Active Ingredient for Enhancing Cutaneous Mechanical Strength, Active Ingredient and Compositions - The object of the invention is a process for obtaining an active ingredient for increasing the mechanical strength of the skin, wherein the process utilizes the following steps:
| 11-20-2008 |
20080287553 | PHARMACEUTICAL COMPOSITIONS COMPRISING PERANHYDROCYCLODEXTRIN - The present invention relates to a pharmaceutical composition comprising a peranhydrocyclodextrin, a drug and a carrier, to the use of a peranhydrocyclodextrin as a drug transport enhancer (e.g. permeation enhancer), and to the use of a peranhydrocyclodextrin in the preparation of a pharmaceutical composition as a synergistic adjunctive system. | 11-20-2008 |
20090018217 | VOLATILE SULFIDE PRODUCTION INHIBITOR AND METHOD FOR INHIBITING THE PRODUCTION OF VOLATILE SULFIDE USING THE INHIBITOR - The object of the present invention is to establish a volatile sulfide production inhibitor that can inhibit the production of volatile sulfides from a composition and to provide a method for inhibiting the production of volatile sulfides from a composition by using the inhibitor. The object are solved by providing a volatile sulfide production inhibitor comprising L-ascorbic acid 2-glucoside as an effective ingredient and a method for inhibiting the production of volatile sulfides from a composition by incorporating the volatile sulfide production inhibitor into the composition. | 01-15-2009 |
20090054537 | THERAPEUTIC PROTOCOLS USING HYALURONAN - The present invention relates generally to the field of therapeutics and in particular, chemotherapy. Even more particularly, the present invention provides therapeutic strategies which reduce the toxicity or enhance the efficacy of chemotherapeutic agents. Compositions and methods of treatment and prophylaxis are also contemplated by the present invention. | 02-26-2009 |
20090131541 | Gelatin-containing topical composition - This invention provides a topical pharmaceutical or cosmetic composition comprising a pharmaceutically or cosmetically active agent and a gelling agent, characterized in that said gelling agent comprises a fish gelatin and a polysaccharide. | 05-21-2009 |
20090131542 | Emulsifier Combination, Emulsion Containing the Emulsifier Combination, and a Process for its Production - An emulsifier concentrate containing: (a) a C | 05-21-2009 |
20090156693 | OPHTHALMIC COMPOSITIONS CONTAINING POLYSACCHARIDE/BORATE GELLING SYSTEM - Topical ophthalmic compositions that form a gel or partial gel upon application to the eye are described. The compositions are particularly useful as artificial tears and ocular lubricants, but may also be utilized for the topical delivery of pharmaceutically active compounds to the eye. The compositions contain a polysaccharide/borate gelling system. The polysaccharides that may be utilized contain cis-diol groups and have a structure that is predominately linear, with a slight degree of branching. | 06-18-2009 |
20090192232 | Supplementary Food Composition For Reducing Body Odor - This invention relates to a food supplement for reducing body odor; it is a mixture of edible carriers with chitin aqueous solution lyophilized powder, chitosan aqueous solution lyophilized powder, chitin powder, chitosan powder, or the composition of these ingredients, and it comes in the form of tablets or pills. The invention has an outstanding effect in reducing various types of body odors, including Koreans' unique body odor, such as Kimchi smell or garlic smell, westerners' unique body odor, such as cheese smell or butter smell, Arabs' unique body odor, such as mutton smell, armpit odor and body odor that is unique in the aged. | 07-30-2009 |
20090197974 | NATURAL DIETARY SUPPLEMENT TABLET - An all-natural or substantially all-natural dietary supplement in a tablet form that comprises at least 95 percent Certified Organic ingredients by weight and exhibits desirable hardness, friability and release of the active dietary supplement is formulated with naturally occurring saccharides that exhibit tablet binder, tablet disintegrant, or both tablet binder and tablet disintegrant functionality. The resulting tablets may be labeled as “natural” dietary supplements. | 08-06-2009 |
20090203803 | N-acylated chitinous polymers and methods of use thereof - The invention pertains to N-acetylated, N, O-carboxyalkylchitosans and methods for using the chitosans to treat disorders, such as cancer, nervous system disorders, urinary tract disorders, and reproductive tract disorders. | 08-13-2009 |
20090209662 | ISOMALTULOSE WITH IMPROVED FLOWABILITY - The invention concerns a crystalline isomaltulose product having improved flow properties as bulk product and no tendency toward long-time compaction, method for production of this product as well as a new use of isomaltulose. | 08-20-2009 |
20090281198 | MOISTURIZER - The present invention provides a moisturizer comprising, as an active ingredient, a saccharide having 3-O-α-D-glucopyranosyl-D-glucose as a structural unit. The moisturizer of the present invention improves the water retention capacity of the stratum corneum, and is useful for prevention and improvement of rough skin. | 11-12-2009 |
20100016451 | Orally Disintegrative Dosage Form - The present invention features an orally disintegrating dosage form including from about 5% to about 40%, by weight, of at least one hydrated salt and a pharmaceutically active agent, wherein the at least hydrated salt has a dehydration temperature of from about 20 to about 120° C. | 01-21-2010 |
20100029789 | Load Bearing Hydrogel Implants - The present invention features dual network hydrogels that possess the structural, mechanical, and biological properties required of load bearing three-dimensional support structures. | 02-04-2010 |
20100036001 | HEPAROSAN POLYMERS AND METHODS OF MAKING AND USING SAME FOR THE ENHANCEMENT OF THERAPEUTICS - The present invention includes compositions, methods, and systems for the development and use of heparosan, a natural polymer related to heparin, as a new therapeutic modifying agent or vehicle which can modulate drug cargo pharmacokinetics and behavior within a mammalian patient. | 02-11-2010 |
20100093875 | GRANULAR PREPARATION PREVENTED FROM CAKING - The present invention provides a granular preparation that resists caking during preservation, namely, a granular preparation characteristically with suppressed caking, which comprises an active ingredient other than biguanide, a sugar or a sugar alcohol, an organic acid and a particular water-soluble polysaccharide; and a method of suppressing caking of a granular preparation, which includes adding a particular water-soluble polysaccharide to the active ingredient, sugar or sugar alcohol and organic acid. | 04-15-2010 |
20100105783 | Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same - A method and packaging machine for preparing rapidly disintegrating formulations for oral administration are disclosed. The present invention is characterized in that a powdery mixture including a pharmaceutically active ingredient and a sugar or a sugar alcohol powder is filled into a packaging material and, thereafter, the mixture, filled in the packaging material, is heated. The present invention can simply and economically prepare an oral formulation which undergoes rapid disintegration in the oral cavity and provides for high-quality administration to patients. | 04-29-2010 |
20100113618 | Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same - The composition disclosed is a pseudo-thermosetting neutralized chitosan composition, neutralized with a hydroxylated base, forming a phosphate-free transparent hydrogel at a temperature higher than 5° C. Said composition contains a homogeneously reacetylated chitosan derived from a chitosan having a deacetylation degree of 80-90%, having a molecular weight of not smaller than 200 kDa and a deacetylation degree of 30-60%, and may further contain a diol. Said composition may be used as a drug delivery system. | 05-06-2010 |
20100137456 | Polysaccharides functionalized by tryptophan derivatives - The present invention relates to novel polysaccharide derivatives, predominantly comprising glycosidic bonds of (1,4), (1,3) and/or (1,2) type, functionalized by at least one tryptophan derivative. It also relates to processes for the synthesis thereof, to their uses as pharmaceutical excipient and to the pharmaceutical compositions comprising them. | 06-03-2010 |
20100168252 | SUGAR DERIVATIVES, METHOD FOR PREPARATION THEREOF, THEIR USE AS SURFACE-ACTIVE AGENTS - Composition (C) comprising for 100% of its mass: from 0.5% to 30% of one or more alcohols having the formula (IV): R1-OH (IV) wherein R1 represents a saturated or unsaturated, linear or branched aliphatic group, having from 8 to 36 carbon atoms, optionally substituted with one or more hydroxyl and/or groups and by 70% to 99.5% of one or more compounds having the formula (I): | 07-01-2010 |
20100174001 | ANTIOXIDANT FOR FOOD - The present invention relates to the technical field of additives or adjuncts, especially additives that have an antioxidant effect and antioxidants, for food products, animal feed, cosmetics, and pharmaceuticals. The present invention above all provides an improved antioxidant agent for food products, animal feed, cosmetics, and pharmaceuticals and also provides compositions that include this antioxidant agent as preferably the sole supplementary additive that has an antioxidant effect. | 07-08-2010 |
20100190872 | PRODUCTION OF BETA-GLUCANS AND MANNANS - Disclosed are methods for producing yeast β-glucan and mannan preparations. The methods employ an autolysis process, followed by enzymatic treatment with one or more of a protease, glucanase or lipase. The preparations produced may be used in food supplements, pharmaceuticals, cosmetics, animal feeds, and neutraceuticals. | 07-29-2010 |
20100204346 | NOVEL SWEETENER HAVING SUCROSE-LIKE TASTE, METHOD FOR PRODUCING THE SAME, AND USE OF THE SAME - Problem: To develop a method for producing a novel sweetener containing glucose, fructose, and psicose, which is produced from glucose liquid sugar using an isomerase and an epimerase; use of the novel sweetener as a food or drink material; and a novel sweetener capable of preventing obesity caused by the intake thereof. | 08-12-2010 |
20100249250 | REVERSIBLE BIOGEL FOR MANIPULATION AND SEPARATION OF SINGLE-WALLED CARBON NANOTUBES - The invention provides the use of novel, binary guanosine gels for simple, rapid and nondestructive solubilization of individual single walled carbon nanotubes (SWNTs) at high concentrations. The gels exhibit selectivity between metallic and semiconducting SWNTs and, further, among SWNTs with different chiralities. | 09-30-2010 |
20100267847 | METHOD OF IMPROVING SWEETNESS QUALITIES OF STEVIA EXTRACT - The present invention provides a technique for improving the sweetness of | 10-21-2010 |
20100280133 | AQUEOUS EMULSION CONTAINING A CYCLODEXTRIN DERIVATIVE, A PERFUME, AND A POLYSORBATE - Aqueous fragrance emulsions are prepared from a hydrophobic fragrance substance, a cyclodextrin derivative, and a polysorbate. The emulsions are stable despite containing a high proportion of fragrance and can be used to prepare uniform coatings on substrates. | 11-04-2010 |
20100311845 | GLYCOSIDASE ENZYMES - A thermostable glycosidase enzymes derived from various | 12-09-2010 |
20100331428 | Sonic Low Pressure Spray Drying - This invention provides methods of spray drying pharmaceutical powders from a vibrating nozzle at low pressures. The method can effectively spray dry thick or viscous solutions or suspensions to provide small uniform particles. The invention includes dry particle compositions prepared by methods of low pressure spraying from vibrating nozzles. | 12-30-2010 |
20100331429 | O/W EMULSIONS CONTAINING A HYDROPHOBIC MODIFIED INULIN AND AT LEAST ONE THICKENING POLYSACCHARIDE OF PLANT ORIGIN - The invention relates especially to a composition in the form of an oil-in-water emulsion comprising an inner fatty phase and an outer aqueous phase and containing: a) at least 0.01% by weight and preferably at least 0.05% by weight, relative to the total weight of the composition, of at least one inulin modified with hydrophobic chains, and b) at least 0.05% by weight and preferably at least 0.1% by weight, relative to the total weight of the composition, of at least one thickening polysaccharide of plant origin, the said composition being free of silicones. The invention also relates to a cosmetic process using the said composition. | 12-30-2010 |
20110039950 | Alkyl and/or Alkenyl Ethers of Alkyl and/or Alkenyl (Poly)Glycosides and Their Use - The present invention relates to nanoemulsions comprising alkyl and/or alkenyl ethers of alkyl and/or alkenyl (poly)glycosides, to a method for their preparation and also to their use. The present invention further relates to the alkyl and/or alkenyl ethers of alkyl and/or alkenyl (poly)glycosides themselves, and their use. | 02-17-2011 |
20110130473 | DILUTE FILTRATION STERILIZATION PROCESS FOR VISCOELASTIC BIOPOLYMERS - Manufactured hyaluronic acid products are used in numerous surgical applications including viscoelastic supplementation for the treatment of osteoarthritis, however, traditional sterilization techniques result in the breakdown of such high molecular weight viscoelastic biopolymers and are thus unsuitable. Disclosed are processes for obtaining concentrated sterile solutions of high molecular weight biopolymers such as hyaluronic acid. The processes include filter sterilization with a dilute preparation of the biopolymer, and concentration of the dilute filter sterilized biopolymer by ultrafiltration to a desired concentration. | 06-02-2011 |
20110160311 | Sweetness Enhancers, Compositions Thereof, and Methods for Use - Disclosed herein are sweetener compositions comprising at least one sweetener and at least one sweetness enhancer chosen from terpenes (such as sesquiterpenes, diterpenes, and triterpenes), flavonoids, amino acids, proteins, polyols, other known natural sweeteners (such as cinnamaldehydes, selligueians, hematoxylins), secodammarane glycosides, and analogues thereof, wherein the at least one sweetness enhancer is present in the composition in an amount at or below the sweetness detection threshold level of the sweetness enhancer, and the at least one sweetener and the at least one sweetness enhancer are different. Also disclosed herein are methods for enhancing sweetness of a composition, comprising combining at least one sweetener and at least one sweetness enhancer chosen from terpenes (such as sesquiterpenes, diterpenes, and triterpenes), flavonoids, amino acids, proteins, polyols, other known natural sweeteners (such as cinnamaldehydes, selligueians, hematoxylins), secodammarane glycosides, and analogues thereof, wherein the at least one sweetness enhancer is present in the composition in an amount at or below the sweetness detection threshold level of the at least one sweetness enhancer, and the at least one sweetener and the at least one sweetness enhancer are different. | 06-30-2011 |
20110190401 | DEPOLYMERIZED POLYSACCHARIDE-BASED HYDROGEL ADHESIVE AND METHODS OF USE THEREOF - The present invention provides novel polysaccharide-based adhesive hydrogel compositions useful for wound healing and topical and transdermal delivery of therapeutic and cosmetic agents, methods of preparation and uses thereof. The hydrogel includes modified polysaccharides which bestow superior cohesion and adhesiveness to the hydrogel. The present invention further provides methods and a device useful for the testing the adhesive properties of hydrogels. | 08-04-2011 |
20110224311 | Natural Product Sweetness Enhancers - The present invention is directed to the use of a compound of Formula I, | 09-15-2011 |
20110230569 | LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT - The present invention provides a formulation comprising:
| 09-22-2011 |
20110263723 | Pigment Composition Comprising Anthocyanic Vacuolar Inclusions - The invention provides a pigment composition comprising anthocyanic vacuolar inclusions or “AVIs” from a plant, and an acceptable carrier. The invention also provides methods for colouring products with the pigment composition, and products comprising the pigment composition or AVIs. | 10-27-2011 |
20110263724 | THREADS OF HYALURONIC ACID AND/OR DERIVATIVES, THEREOF, METHODS OF MAKING THEREOF AND USES THEREOF - The present invention provides threads of hyaluronic acid, and/or derivatives thereof, methods of making thereof and uses thereof, for example, in aesthetic applications (e.g., dermal fillers), surgery (sutures), drug delivery, etc. | 10-27-2011 |
20110288182 | HEALTH CHARACTERISTIC DULCE DE LECHE CONFECTION COMPOSITIONS AND FLAVORED MILK - The present invention provides for Dulce de Leche confection compositions and Dulce de Leche based flavored milk that has an improved, healthier fat structure, unique antioxidant taste profile, lower sugar content, fiber component, and a 0% or greater supplement component that can add additional dietary benefits. Cholesterol reduction can be accomplished within certain embodiments of this invention. Specific ratios of ingredients within our compositions create a taste, texture, mouth feel, and rich and creamy true Dulce de Leche confection without the negative health ramifications of high milk fat content and sugar content characteristic of traditional Dulce de Leche products. Additionally, the method for preparing these Dulce de Leche confection products and flavored milk are covered. | 11-24-2011 |
20110294903 | LARGE PARTICLE SIZE CRYSTALLISED MALTITOL POWDER, METHOD FOR PREPARING SAME AND APPLICATIONS THEREOF, PARTICULARLY IN CHOCOLATE PRODUCTION - A crystallized maltitol powder including a maltitol content greater than 99.5% by weight, characterized by a particle-size distribution by volume, determined by laser granulometry, having less than 20% particles less than 200 μm in size, less than 6% particles less than 100 μm in size, less than 2% particles less than 40 μm in size and a pour value less than or equal to 10 seconds, an aerated density greater than 0.85 g/ml, a compacted density greater than 0.97 g/ml, and a compressibility of less than 17%, and to its use in the pharmaceuticals and above all foods sectors, in particular in the formulation of chocolates or table sweeteners. | 12-01-2011 |
20110301249 | STEM CELL ENHANCED PROTEIN PRODUCTS AND USES THEROF - Methods for producing in-vitro cultured protein products that are enhanced with stem cells are disclosed. In-vitro cultured protein product compositions produced by said methods are also disclosed. The present invention also discloses methods of providing nutrients to an animal by feeding said animal with said in-vitro cultured protein products. | 12-08-2011 |
20110306679 | COMPOSITIONS CONTAINING AGAR AND A SOFTENING AGENT - The present invention includes a composition that has (a) at least one thermo-reversible polysaccharide chosen from agar; (b) at least one softening agent chosen from a cationic surfactant, an anionic surfactant, a nonionic esterified sugar surfactant, a polyorganosiloxane-containing polymer, a sugar silicone surfactant, and mixtures thereof; (c) at least one oil; and (d) water. | 12-15-2011 |
20110306680 | COMPOSITIONS CONTAINING AGAR AND ESTERIFIED SUGAR SURFACTANTS - The present invention is directed to a composition that includes (a) at least one thermo-reversible polysaccharide chosen from agar; (b) at least one softening agent chosen from an esterified sugar surfactant; (c) at least one oil; (d) water; and (e) optionally, at least one emulsifier different from (b), as well as to processes for softening an emulsion containing agar by adding to the emulsion at least one softening agent chosen from an esterified sugar surfactant. | 12-15-2011 |
20110313055 | HEALTH CHARACTERISTIC CHEWY OR GUMMY CANDY CONFECTION - The present invention provides for flavored chewy or gummy candy confections made by making a flavored chewy or gummy candy confection from scratch or adjusting a current flavored chewy or gummy candy confection brand product with our invention. This invention can have a healthier group of edible oils component, unique antioxidant taste profile component, fiber component, water component, emulsifier component, and potentially a 0% or greater supplement component that can add additional dietary benefits. Specific ratios of ingredients can lower sugar content up to 75% while creating a product with a taste, texture, and mouth feel similar to regular flavored chewy or gummy candy. The reduction of sugar possible within this invention can reduce the negative health ramifications of high sugar content that current flavored chewy or gummy candy confections suffer from and the addition of the healthier ingredients adds some improved health characteristics to the products that usually are devoid of nutrition. Additionally, the method for preparing a flavored chewy or gummy candy confection with these improved health characteristics, taste profile, and dietary benefits are covered. | 12-22-2011 |
20110313056 | GEL FORMATION OF POLYELECTROLYTE AQUEOUS SOLUTIONS BY THERMALLY INDUCED CHANGES IN IONIZATION STATE - There is disclosed aqueous solutions of polyelectrolytes that can be neutralized by increasing temperature, under suitable polyelectrolyte charge state conditions, in order to obtain a homogeneous gel. This can be achieved by adding an appropriate weak electrolyte to the polyelectrolyte so that an increase of temperature will lead to a spatially homogeneous neutralization of the polyelectrolyte via proton transfer between the polyelectrolyte and the weak electrolyte. The ability of such a system to be thermally sensitive and to gel upon heating relies on the temperature dependence of the ionization equilibrium for the two components. This thermally induced neutralization reduces electrostatic repulsion between polyelectrolyte molecules allowing the manifestation of attractive polyelectrolyte-polyelectrolyte hydrophobic interactions and hydrogen bonding that result in gel formation. These new kinds of thermo sensitive gels can be used for biomedical applications. | 12-22-2011 |
20110319502 | Compositions and Methods for Enhancing Reduction of Spore-Forming Microorganisms - A pharmaceutical formulation comprises a pharmaceutically acceptable preservative and a material selected from the group consisting of D-glucose, sucrose, maltose, D-mannose, trehalose, glutamic acid, mixtures thereof, and combinations thereof, wherein the formulation has enhanced preservative efficacy against spore-forming microorganisms. The formulation can further comprise boric acid and/or phosphate. A method for enhancing the preservative efficacy of a pharmaceutical formulation against spore-forming microorganisms, comprising adding a pharmaceutically acceptable preservative, and a material selected from the group consisting of D-glucose, sucrose, maltose, D-mannose, trehalose, glutamic acid, mixtures thereof, and combinations thereof, to the pharmaceutical formulation. The formulation optionally includes an active agent for treating or controlling a disease or disorder of the eye. The formulation may be used to treat, clean, disinfect, store, wet, or rewet contact lenses. | 12-29-2011 |
20120022170 | MANUFACTURE OF TABLET IN A DIE UTILIZING POWDER BLEND CONTAINING WATER-CONTAINING MATERIAL - The present invention features the present invention features a process for making a tablet by compacting a powder blend in a die platen to form a tablet shape, wherein the powder blend includes a pharmaceutically active agent and a water-containing material, and applying energy to the tablet shape for a sufficient period of time to heat the water-containing material within the tablet shape above its dehydration temperature to form the tablet. | 01-26-2012 |
20120035277 | LIQUID-FILLED CHEWABLE SUPPLEMENT - A liquid-filled chewable composition for the oral delivery of nutritional supplements and/or pharmaceuticals is provided. The chewable composition includes a delivery vehicle and an active ingredient incorporated therein. The delivery vehicle may include an organic or non-organic gummy candy including a binding agent, sweetener, flavoring, and/or coloring. The active ingredient may include a predetermined amount of any combination of pharmaceuticals, nutraceuticals, vitamins, minerals, antioxidants, soluble and insoluble fiber, herbs, plants, probiotics, prebiotics, antioxidants, amino acids, fatty acids, digestive enzymes, dietary supplements, or any other health promoting ingredient. The delivery vehicle may also include a predetermined amount of at least one nutritional supplement and/or pharmaceutical compound. | 02-09-2012 |
20120041078 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER - The present invention includes methods of stabilizing one or more sweet enhancers when they are exposed to a light source as well as liquid compositions containing one or more sweet enhancers and one or more photostabilizers. | 02-16-2012 |
20120041079 | DEXTRAN FUNCTIONALIZED BY HYDROPHOBIC AMINO ACIDS - Dextran of the following general formula I: | 02-16-2012 |
20120059071 | High-Purity Mogrosides And Process For Their Purification - The present invention provides a process for preparation of highly purified mogrosides mixture from low purity mogrosides mixture. The process comprises providing a mixture of low purity mogrosides, dissolving the low purity mogrosides mixture in water or an aqueous alcohol solution to form an initial solution of mogrosides, passing the initial solution through a column system, wherein the column system comprises a plurality of columns, and each column is packed with a sorbent having different affinities to impurities and mogrosides so that one or more columns retains more mogrosides than other columns, washing the columns to remove impurities with an acidic aqueous solution, a basic aqueous solution, and an aqueous alcoholic solution successively, eluting the columns with an aqueous alcohol solution that contains higher alcohol content than the aqueous alcohol solution used in the washing step, wherein the eluate from the columns with high content of mogrosides are combined, and drying the combined eluate to obtain high purity mogrosides with the content of the total mogrosides are more than 70% (w/w). The present invention also provides a sweetener mixture and product comprising high purity mogrosides. | 03-08-2012 |
20120071567 | FRUIT FLAVORED COCOA BUTTER BASED CONFECTION - A fruit flavored confection made of a fruit based anhydrous component, along with sweeteners dairy and suitable confectionary fat wherein the intimate incorporation of the fruit based component and the acidic pH of the confection results in a vibrant fruit flavor profile. | 03-22-2012 |
20120071568 | Cosmetic Composition - An object of the invention is to provide a cosmetic composition that is not drippy during makeup removal, has good skin spreadability during use, has a refreshing feeling in use, and provides a high cleansing effect, and in particular, to provide a cleansing composition. The cosmetic composition according to the invention is characterized by comprising (A) an alkyl ethylene oxide surfactant having an HLB of 8 to 13, (B) 10 to 40 mass % of an oil component, and (C) water, wherein the composition is a discontinuous-micellar cubic liquid-crystal phase. Also the cosmetic composition is characterized by comprising the above composition as the outer phase and (B | 03-22-2012 |
20120115964 | XANTHAN GUM AND SWELLABLE PARTICULATE CONTAINING COMPOSITION AND USES THEREOF - This invention relates to a composition comprising at least about 0.2% w/w xanthan gum and at least about 6% w/w of a swellable particulate, and to uses thereof. | 05-10-2012 |
20120129953 | TINGLING AND SALIVATING COMPOSITIONS - A sensate composition comprises a salivating component, a tingling component and a flavor, the salivating component being formed of at least a mixture of citric, malic and succinic acid, or of their salts, and the tingling component being formed of an ingredient selected from the group consisting of Jambu oleoresin, spilanthol, any extract containing either or both, and their mixtures. The sensate composition allows the preparation of consumer products having improved salivating properties. | 05-24-2012 |
20120136071 | Medicinal Cream For Diaper Rash And A Process To Make It - The present invention relates to a composition for treating diaper rash along with skin rejuvenation. More particularly, the present invention relates to a pharmaceutical cream comprising a biopolymer, and an anti diaper rash active ingredient. It discloses a composition for treating diaper rash along with skin rejuvenation containing a) a biopolymer in the form of chitosan, b) a combination of active ingredients used in treating diaper rash, c) a cream base containing primary and secondary emulsifiers, waxy materials, co-solvents, acids, preservatives, buffering agents, anti oxidants, chelating agents, and humectants, and d) water. The active ingredients, namely chitosan, and diaper rash agents, are incorporated in cream base for use in treating diaper rash. | 05-31-2012 |
20120149783 | WATER-IN-OIL EMULSION COMPOSITIONS CONTAINING GELLAN GUM FOR TOPICAL DELIVERY OF ACTIVE INGREDIENTS TO THE SKIN OR MUCOSA - The present invention is directed to water-in-oil (W/O) emulsion compositions containing gellan gum which provide an enhanced rate of release of active ingredients for delivery to the skin or mucosa. | 06-14-2012 |
20120149784 | TABLETTING OF ERYTHRITOL AND ISOMALT - Erythritol is granulated together with from 10% w/w to 50% w/w isomalt. Chewable tablets are prepared and the corresponding process is described. | 06-14-2012 |
20120157553 | Methods for Using Rebaudioside C as a Flavor Enhancer - The present invention is directed to the use of one or more rebaudioside C polymorphs, or stereoisomers thereof, to enhance the sweet taste of a flavoring, such as glucosylated steviol glycoside, rebaudioside A, ammoniated glycyrrhizin, neohespherdin dihydrochalcone or thaumatin. | 06-21-2012 |
20120190757 | FORMULATIONS AND METHODS FOR SOLID CHITOSAN-CONTAINING BLENDS - Chitosan-containing blends and methods of dissolving and using chitosan are disclosed. A blend includes a solid acid or a solid agent that generates a proton in situ in the presence of water mixed together with a dry solid chitosan, and may optionally contain other components. The blends are in a dry, free-flowing, particulate form. Methods of dissolving a blend typically comprise adding a quantity of the blend to a low volume of water and mixing until the chitosan and solid acid or solid agent are dissolved and then further diluting this mixture by the addition of water, or used as-is. Devices containing the blends are also described along with methods of using the devices, such as for controlled release of solubilized chitosan in a body of water, such as a stream, containing impurities (e.g., particles, sediment, or suspended matter or dissolved substances) to cause flocculation or precipitation of such impurities. | 07-26-2012 |
20120196941 | ABSORPTION ENHANCERS FOR DRUG ADMINISTRATION - A composition including a surfactant and at least one alkyl glycoside and/or saccharide alkyl ester and a drug. The surfactant composition(s) when admixed with a drug is non-toxic and non-irritating, while stabilizing and increasing the bioavailability of the drug. The invention also provides compositions that enhance absorption of drugs via the oral, ocular, nasal, nasolacrimal, inhalation or pulmonary, oral cavity (sublingual or Buccal cell) or CSF delivery route of a patient, including but not limited to insulin, glucagon and exendin-4. | 08-02-2012 |
20120220668 | MEMBRANE STABILIZING COMPOSITIONS AND METHODS - A sugar-anchor polymer and methods of making and using the same to stabilize a lipid membrane. The sugar-anchor polymer includes a sugar covalently bound to a first anchor and a second anchor wherein the covalent bonds are selected from the group consisting essentially of an oxime bond, a hydrazone bond, an acylhydrazide bond, an aminothioacetal bond, an acetal bond, a thioacetal bond, a dithioacetal bond, a thioether bond and combinations thereof. The method includes reacting a sugar having at least two nucleophilic moieties with at least two anchors, each anchor having at least one electrophilic moiety, to form the polymer. Alternatively, the method includes reacting a sugar having at least two electrophilic moieties with at least two anchors, each anchor having at least one nucleophilic moiety, to form the polymer. The anchors may be lipids or peptides. The sugar-anchor polymers stabilize lipid membranes against serum proteins, dehydration, and cryopreservation. | 08-30-2012 |
20120232166 | Masking Bitter Flavors - Mogrosides may be used as a flavor modifier in various foods, beverages, pharmaceutical compositions, and the like to block the perception of bitter and astringent flavors or other off flavors. | 09-13-2012 |
20120238643 | INACTIVATION OF OFF-TASTE INDUCING ENZYMES - The present inventions relates to a method for the production of gellan gum, under mixing conditions, the method comprising a) providing a fermentation broth or other liquid medium containing gellan gum, b) if necessary adjusting the temperature and the pH of the fermentation broth/liquid medium to allow or facilitate enzymatic treatment in step c, c) adding one or more enzymes capable of reducing or abolishing the enzymatic activity of | 09-20-2012 |
20120245234 | COSMETIC AND DERMATOLOGIC COMPOSITION AND USES THEREOF - The present invention relates to a novel natural composition comprising sclerotium gum, xanthan gum and pullulan and intended for preparing cosmetic and dermatologic compositions, to the uses thereof, and to the cosmetic and dermatologic compositions containing said novel natural composition. | 09-27-2012 |
20120264831 | REBAUDIOSIDE-MOGROSIDE V BLENDS - A composition includes Mogroside V and a Rebaudioside component in a weight ratio ≧1:1 and ≦6:1, wherein the Rebaudioside component consists of one or more compounds selected from the group consisting of Rebaudioside A, Rebaudioside B and Rebaudioside D. A method of purifying a Luo Han Guo extract includes contacting the Luo Han Guo extract with activated carbon and a macroporous polymeric adsorbent resin, an ion exchange resin, or both. A composition includes a Luo Han Guo extract, wherein Mogroside V constitutes from 50 wt % to 75 wt % of the Luo Han Guo extract and the composition includes from 0 to 13 wt % in total relative to the Mogroside V of aromatic glycosides, and from 0 to 15 ppm of semi-volatile organic compounds relative to the Mogroside V. | 10-18-2012 |
20120264832 | Low Inflammatory Blended Oils - A low inflammatory oil composition and method for supplementing feed, nutrition and diet systems with omega-3 to omega-6 balanced oils comprised of a synergistic blend of at least two oils. The composition further comprises a synergistic blend of long chain omega-3 oil as a means to further increase the nutritional value. The composition further provides an effective increase in reducing inflammation for therapeutic, and pharmacological treatment in addition to general nutrition and diet systems. | 10-18-2012 |
20120283338 | SWEETENER COMPOSITIONS AND METHODS OF MAKING THE SAME - Disclosed is a method of preparing a composition by mixing a sweetener and an ingredient, pressing the sweetener and ingredient together to form a pressed mixture in the form of a sheet, briquette, pellet, flake or other form, and reducing the pressed mixture to yield a composition. The composition comprises particulates having a desirable size, where a particulate comprises the ingredient at least partially embedded within the sweetener. The composition can be used in a variety of food, dietary and pharmaceutical products. | 11-08-2012 |
20120289611 | PECTIN COMPOUNDS, METHODS OF USING PECTIN COMPOUNDS, AND METHODS OF CONTROLLING WATER SOLUBILITY - Briefly described, embodiments of the present disclosure provide for compositions including pectin compounds, pectin compounds, methods of making pectin compounds, methods of controlling the water solubility of a pectin compound, methods of controlling the water solubility of an agent, beads including pectin compounds, and the like. | 11-15-2012 |
20120289612 | Composite Material and Method for Producing the Same - It has been necessary to use a relatively large amount of cyclodextrin in order to produce a composite material, but the amount of the cyclodextrin needs to be reduced from the viewpoint of costs; in this respect, the present invention provides a composite material comprising a food or active pharmaceutical ingredient, a phytosterol ester, a medium-chain fatty acid triacylglyceride, and a cyclodextrin. | 11-15-2012 |
20120309853 | ALDOHEXOSE-BASED FLUOROADDITIVES - Compositions comprising compounds having an aldohexose moiety, a highly fluorinated moiety, and a nitrogen-containing functional group linking the moieties together are disclosed. The aldohexose-based fluoroadditives are effective in reducing the surface tension of water and are useful in various surfactant applications. Also disclosed are processes for making aldohexose-based fluoroadditives. | 12-06-2012 |
20120309854 | ALDOHEXOSE-BASED FLUOROADDITIVES - Compositions comprising compounds having an aldohexose moiety, a highly fluorinated moiety, and a nitrogen-containing functional group linking the moieties together are disclosed. The aldohexose-based fluoroadditives are effective in reducing the surface tension of water and are useful in various surfactant applications. Also disclosed are processes for making aldohexose-based fluoroadditives. | 12-06-2012 |
20130012599 | SURFACE TREATMENT FOR GASIFIED CONSUMABLE MATERIALS - A surface treatment for the preparation of gasified consumable materials comprising active ingredients. The surface treatment may comprise a combination of flavors, sweeteners, and active ingredients such as nutritional supplements and/or pharmaceuticals. The invention avoids the degradation of active ingredients during the manufacturing process since the active ingredients are applied to the surface of the composition and not cooked with the gasified consumable material. Methods for making and using the disclosed compositions are also within the scope of the invention. | 01-10-2013 |
20130030060 | Glucosyl Stevia Composition - Glucosyl stevia compositions are prepared from steviol glycosides of | 01-31-2013 |
20130035403 | CELLS, NUCLEIC ACIDS, ENZYMES AND USE THEREOF, AND METHODS FOR THE PRODUCTION OF SOPHOROLIPIDS - The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids. | 02-07-2013 |
20130046028 | Cosmetic Raw Material - A cosmetic raw material comprising the following components (A), (B), and (C): (A) a specific polyether-modified organopolysiloxane; (B) a chain-form silicone oil that is a liquid at 25° C., does not contain a cyclic structure, and does not contain a resinous structure; and (C) an oil that is a liquid at 30° C. and that characteristically (c1) has at least one hydroxyl group in each molecule, (c2) has from 0 to 3, as the number of moles of addition, oxyethylene units in each molecule, (c3) has an HLB value in the range from 0.1 to 6.0, and (c4) has an average molecular weight in the range from 200 to 7000. | 02-21-2013 |
20130053453 | DERMAL FILLER COMPOSITION - The present invention relates to a novel dermal filler composition and a method for preparing the same. Even though the composition of the present invention comprises, as a main component, only cross-linked dextran having the molecular weight of 30,000 to 100,000, the composition can rapidly augment a detective area of the skin and maintain softness to the touch even, the composition eliminates the necessity of a pretreatment, such as an allergy test, which might otherwise be required prior to injection, is inexpensive, and is not easily decomposed or absorbed in vivo, thereby stably maintaining the tissue-volume augmentation effects after injection over a long period of time. | 02-28-2013 |
20130072578 | ORODISPERSIBLE TABLETS OF ERYTHRITOL AND ISOMALT - Erythritol is granulated together with at least 10% w/w isomalt. Prior and/or after granulation a disintegrant is added and orodispersible tablets are prepared. The tablet has a disintegration time of less than 100 seconds, less than 90 seconds, preferably less than 80 seconds, more preferably less than 60 seconds and said disintegration time was determined according to the European Pharmacopoeia VI, Test method 2.9.1 by using a pharmaceutical disintegration tester model ZT 73 whereby 6 tablets having a surface of 1 square centimeter and a weight of 350 mg, at a compression force of 20 kN, were analyzed and mean values were calculated. The process for preparing the orodispersible tablet, its use, and the intermediate granulate are described as well. | 03-21-2013 |
20130079422 | OPHTHALMIC CONTACT LENS SOLUTIONS CONTAINING FORMS OF VITAMIN B - The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions. | 03-28-2013 |
20130085187 | DEACETYLATION HYDROLASE OF HYALURONIC ACID, HYALURONIC ACID DEACETYLATED BY SAME AND DERIVATIVE THEREOF - The present disclosure relates to a deacetylation hydrolase of a hyaluronic acid a hyaluronic acid deacetylated by same and a derivative thereof. The deacetylated hyaluronic acid and the derivative thereof have the following characteristic: a delayed initial decomposition rate on a living body; minimized decrease of molecular weight and viscosity; accelerated gelation due to a lower gelation temperature than the gelation temperature for a non-deacetylated hyaluronic acid; and an hMSC survival rate that is hardly affected by increased concentration of the deacetylated hyaluronic acid and the derivative thereof in a culture medium. As a result, the deacetylated hyaluronic acid and the derivative thereof can be useful as a bioingredient such a delivery system for a cell, gene, drug, and the like, or a support for tissue engineering, etc. | 04-04-2013 |
20130131191 | ADDITIVE FOR TABLETS - A disintegrant for tablets includes an α-1,4-glucan having a degree of polymerization of not less than 180 and less than 1230 and a dispersity (weight average molecular weight “Mw”/number average molecular weight “Mn”) of not more than 1.25 or a modified product thereof. A binder for tablets includes an α-1,4-glucan having a degree of polymerization of not less than 1230 and not more than 37000 and a dispersity of not more than 1.25, or a modified product thereof. A binding-disintegrating agent for tablets includes a low molecular weight α-1,4-glucan or a modified product thereof, and a high molecular weight α-1,4-glucan or a modified product thereof. | 05-23-2013 |
20130158132 | Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans - The composition adapted to prolong the residence time of drugs in the circulating plasma of mammals including humans comprises the following: | 06-20-2013 |
20130184356 | CHITOSAN COMPOSITION - This invention provides a composition comprising: (i) a chitosan hydrogel comprising cross-linked chitosan and water; and (ii) a liquid dispersed in the hydrogel. | 07-18-2013 |
20130197103 | COMPOSITION AND METHOD FOR THE ENHANCEMENT OF THE EFFICACY OF DRUGS - The present invention relates to the enhancement of the efficacy of drugs, and more particularly, with overcoming the resistance of cells or organisms to drugs. In particular, the present invention provides a method for enhancing the effectiveness of a cytotoxic or anti-neoplastic agent, comprising the step of co-administering said agent with hyaluronan, wherein co-administration with hyaluronan enhances the agent's cancer cell-killing potential. | 08-01-2013 |
20130197104 | REDUCED SUGAR SYRUPS AND METHODS OF MAKING REDUCED SUGAR SYRUPS - A reduced sugar syrup having an advantageously low viscosity is prepared by hydrolysis of starch or starchy material using a particular type of alpha amylase enzyme which yields a saccharide distribution having a low DP1-2 and low DP11+ content. The DP4 content of the syrup may be favorably increased by using a maltotetragenic alpha amylase enzyme in combination with the aforementioned alpha amylase enzyme. The syrup is useful in the production of food, beverage, animal feed, animal health and nutrition, pharmaceutical, and cosmetic compositions and may be combined with a high intensity sweetener to provide a composition capable of being substituted for conventional corn syrups. | 08-01-2013 |
20130203867 | STEVIA FORMULATION - The invention provides a stevia formulation comprising a stevia sweetener with a rebaudioside A content of 95% or greater, and 0.25 to 5.15 parts by weight of a sugarcane-derived extract (a), 0.06 to 2.50 parts by weight of a sugarcane-derived extract (b) and 0.002 to 12.5 parts by weight of γ-aminobutyric acid with respect to 100 parts by weight of the stevia sweetener. | 08-08-2013 |
20130237613 | SUGAR-BASED SURFACTANT MICROEMULSIONS CONTAINING ESSENTIAL OILS FOR COSMETIC AND PHARMACEUTICAL USE - The present invention relates to a thermodynamically stable, biocompatible, environment friendly, and temperature-insensitive microemulsion containing various botanical essential oils, sugar based surfactants, polyhydric alcohols, and an aqueous phase. | 09-12-2013 |
20130237614 | BIORESORABLE POLYMER MATRICES AND METHODS OF MAKING AND USING THE SAME - A kit for forming a bioerodible composition is provided with a first aliquot portion of a reaction mixture having an aldehydic polymer solution, and a second aliquot portion of a reaction mixture having solids which include a cross-linking hydrazide. When mixed, the first and second aliquot portions of the reaction mixture react at a pH of 4 to 6 to form a solidified bioerodible composition within about 1 to about 10 minutes, to form a hydrazide cross-linked aldehydic polymer matrix. The bioerodable composition may be usefully employed to seal and/or treat wounds (e.g., a surgical incision). | 09-12-2013 |
20130237615 | PROCESS OF PREPARING A CROSSLINKED GEL - The subject of the present invention is a process of preparing a crosslinked gel of at least one polysaccharide or one of its salts, including at least the steps consisting in: a) providing, at a temperature below 35° C., an aqueous gel including at least one polysaccharide in an uncrosslinked form together with at least one difunctional or multifunctional epoxy crosslinking agent; b) maintaining the mixture of step a) at a temperature below 35° C. for at least one hour; c) stimulating the crosslinking reaction of the mixture obtained after step b), and if need be; d) recovering said crosslinked gel formed. | 09-12-2013 |
20130253075 | DERIVATIVES OF NATIVE LIGNIN - The present invention provides derivatives of native lignin having a certain aliphatic hydroxyl content. Surprisingly, it has been found that consistent and predictable antioxidant activity may be provided by selecting for derivatives of native lignin having a certain aliphatic hydroxyl content. | 09-26-2013 |
20130274350 | NOVEL SWEETENER HAVING SUCROSE-LIKE TASTE, METHOD FOR PRODUCING THE SAME, AND USE OF THE SAME - To develop a method for producing a novel sweetener containing glucose, fructose, and psicose, which is produced from glucose liquid sugar using an isomerase and an epimerase; use of the novel sweetener as a food or drink material; and a novel sweetener capable of preventing obesity caused by the intake thereof. An isomerase and an epimerase are allowed to act on glucose liquid sugar produced in a glucose liquid sugar production plant to thereby produce D-psicose, thereby providing a novel sweetener (product) that maintains the degree and quality of sweetness of a glucose-fructose mixed solution and never causes obesity, a method for producing the same, and use of the same. | 10-17-2013 |
20130274351 | HIGHLY SOLUBLE REBAUDISIDE D - The invention relates to a process for producing highly soluble compositions containing purified steviol glycosides from | 10-17-2013 |
20130281548 | COMPOSITIONS COMPRISING A COMBINATION OF AT LEAST ONE COLORANT AND AT LEAST ONE POLYSACCHARIDE - Dispersible colorants that include a combination of a colorant and a polysaccharide are provided, wherein the weight ratio of total colorant to total polysaccharide is in the range of 5000:1 to 1:5000. In one aspect, the colorant is a synthetic or natural colorant. In one aspect, polysaccharide is interpreted very broadly and provides a colored precipitate upon the combination of the colorant with the polysaccharide. | 10-24-2013 |
20130281549 | BIOLOGIC BONDING AGENT - A sterile biofilm could be engineered to isolate the glue-like substance while eliminating the adverse properties of the bacteria. The resulting sterile glue-like substance would be used to help the cells stick to the support structure. The engineered biofilm could be added to the support structure in the laboratory that produces the support structure or just prior to the addition of the cells by the user. Alternatively, the biofilm and support structure could be combined intra-corporally. This biofilm also could be used as an independent polysaccharide based adhesive with mild to moderate adhesion forces. The biofilm could serve as a surgical adhesion or grouting for cells, for tissue fixation (soft tissue to soft tissue, soft tissue to bone, etc.) and as a sealant. The biofilm could be used in conjunction with other implants and devices. The biofilm could be used to coat a stent. | 10-24-2013 |
20130303632 | CONTROLLED RELEASE SOLID DOSE FORM - The present invention is directed to a controlled release solid dosage form comprising a controlled release modifier and an active ingredient comprising at least one of a pharmaceutical, veterinary, or nutraceutical active ingredient, wherein the controlled release modifier comprises lambda carrageenan from the taxonomic order Halymeniales. The present invention is also directed to ethanol resistant controlled release solid dosage forms and methods for reducing the ethanol sensitivity of an active ingredient in a controlled release solid dose form. | 11-14-2013 |
20130310467 | TREHALOSE FATTY ACID ESTER COMPOSITION - The present invention relates to a trehalose fatty acid ester composition, including a trehalose fatty acid ester, wherein all the fatty acid residues held by all the trehalose fatty acid esters in the composition are saturated fatty acid residues having 8 to 22 carbon atoms, the composition contains at least two types of esters selected from the group consisting of a triester, a tetraester, a pentaester, a hexaester, a heptaester, and an octaester, and the sum amount of the esters relative to the total amount of the trehalose fatty acid ester in the composition, is from 20 to 100% by area. According to the present invention, it is possible to provide a composition which has excellent thermostability and an excellent effect of adjusting the hardness for various types of waxes, and which can be used as a solidifier together with a wax for various types of cosmetics. | 11-21-2013 |
20130324621 | Stevia Composition - compositions are prepared from steviol glycosides of | 12-05-2013 |
20130331466 | MODIFIED SOPHOROLIPIDS AS OIL SOLUBILIZING AGENTS - A method for the development of a library of modified sophorolipids using a wide-range of chemical and enzyme catalyst tools to identify modified sophorolipids that can be used in pure form, as mixtures with other modified sophorolipids, as mixtures with natural sophorolipids, as mixtures with modified and natural sophorolipids, and as mixtures with other compounds known by one skilled in the art for use in the dispersion, solubilization or emulsification of various oil types and nutraceuticals, and modified sophorolipids for use in dispersion, solubilization or emulsification processes. | 12-12-2013 |
20140005279 | SUBSTITUTED AROMATIC COMPOUND, HYDROGELATION AGENT, HYDROGEL, AND METHOD FOR GELATING AQUEOUS SAMPLE | 01-02-2014 |
20140011892 | PEARL SUGAR PARTICLE, COMPOSITION, AND PROCESS FOR PREPARING A PEARL SUGAR - A pearl sugar particle includes granulated sugar and at least one additive, wherein the at least one additive is distributed homogeneously throughout the pearl sugar particle. A composition including a plurality of pearl sugar particles and a process for preparing a pearl sugar are also disclosed. | 01-09-2014 |
20140011893 | COMPOSITION AND METHOD - A method of preparing a mucoadhesive film formulation by preparing a film forming composition including lambda carrageenan as a film forming polymer, at a concentration of about 1-7% by weight, a plasticizer at a concentration of about 1-15% by weight, a biologically active substance, and purified water; distributing the film forming composition as a wet film layer onto a solid surface; and allowing the film layer to dry. A mucoadhesive film obtained by the method and a film dosage unit. | 01-09-2014 |
20140018441 | Methods and Apparatus for Assembly - In exemplary implementations of this invention, hierarchical, nanometer-precise assembly is performed: A first structural unit is attached to a solid substrate in a first fluidic flow. A second structural unit is attached to the first structural unit in a second fluidic flow, a third structural unit is attached to the second structural unit in a third fluidic flow, and so on, until a target structure comprising the structural units is assembled. The first, second, third and so on fluidic flows are separate and occur in order in a temporal sequence. During the temporal sequence, a specific permutation of nucleobases is used repeatedly, in separate fluidic flows which occur at different times, to form multiple attachments between structural units in an assembly. The assembled target structure is removed from the solid substrate. Attachments between the structural units may be formed by nucleobase pairing. | 01-16-2014 |
20140080923 | STEVIA BASED SWEETENING COMPOSITION - A liquid composition that includes at least one steviol glycoside dissolved in glycerol, and a method for preparation thereof, preferably at a temperature above 100° C. The steviol glycoside is extracted from | 03-20-2014 |
20140107228 | OILY COSMETIC - [Problems to be solved] In an oily cosmetic product using a filling extrusion container which is used by extruding a filling from a cylindrical storage portion to a tip of ejection portion, an oily cosmetic having smooth usability, excellent makeup durability and temperature stability, and good ejection performance is provided. | 04-17-2014 |
20140128479 | Absorption Enhancers for Drug Administration - A composition including a surfactant and at least one alkyl glycoside and/or saccharide alkyl ester and a drug. The surfactant composition(s) when admixed with a drug is non-toxic and non-irritating, while stabilizing and increasing the bioavailability of the drug. The invention also provides compositions that enhance absorption of drugs via the oral, ocular, nasal, nasolacrimal, inhalation or pulmonary, oral cavity (sublingual or Buccal cell) or CSF delivery route of a patient, including but not limited to insulin, glucagon and exendin-4. | 05-08-2014 |
20140142201 | STEVIA COMPOSITION - compositions are prepared from steviol glycosides of | 05-22-2014 |
20140155497 | HEPAROSAN-BASED BIOMATERIALS AND COATINGS AND METHODS OF PRODUCTION AND USE THEREOF - Biomaterial compositions that include an isolated heparosan polymer are disclosed, as well as kits containing such biomaterial compositions and methods of producing and using such biomaterial compositions. | 06-05-2014 |
20140171519 | COMPOSITIONS AND METHODS FOR IMPROVING REBAUDIOSIDE X SOLUBILITY - Polymorphic and amorphous forms of Rebaudioside X and methods for preparing the same are provided herein. Also provided herein are Rebaudioside X complexes and methods for preparing the same. Sweetener compositions and sweetened compositions comprising Rebaudioside X forms and Rebaudioside X complexes are described, as well as and methods of their preparation. Methods of improving the flavor and/or temporal profile of sweetenable compositions, such as beverages, are also provided herein. | 06-19-2014 |
20140171520 | HIGHLY SOLUBLE STEVIA SWEETENER - A method for making highly soluble | 06-19-2014 |
20140179804 | STEVIA COMPOSITION - Stevia compositions are prepared from steviol glycosides of | 06-26-2014 |
20140194536 | LOW-VISCOSITY LIQUID CRYSTAL COMPOUND - The present invention relates to a liquid crystal compound that can be used as a base for injection formulations. The present invention provides an amphipathic compound having the following general formula (I): | 07-10-2014 |
20140213664 | PROCESSES, PRODUCTS AND METHODOLOGIES FOR MAKING AND USING NOVEL BIOADVANTAGED SWEETENERS - Bioadvantaged Sweeteners leverage chemical synergies of combining select ratios of certain formulations of lactose and glucose with, for example, purified phlorizin for unexpectedly better results than predicted by prior art as a whole. Glucometer data confirms employing such Bioadvantaged Sweetener with conventional and enhanced delivery systems facilitates stasis at points of peak blood sugar saturation for users. | 07-31-2014 |
20140256831 | HYDROGEL AND METHOD FOR PRODUCING SAME - A hydrogel is provided which is obtained by reacting an azide group and a cyclooctyne group in the absence of a catalyst, especially in the absence of a copper catalyst. The hydrogel has: (a) a first polymer moiety composed of hyaluronic acid, carboxymethyl dextran or the like; (b) a second polymer moiety composed of hyaluronic acid, carboxymethyl dextran or the like, said second polymer moiety being of a kind that is same as or different from the kind of the moiety (a) and is composed of a molecule different from the moiety (a); and (c) a triazole ring group or a derivative group thereof. | 09-11-2014 |
20140275291 | BIOCOMPATIBLE AND BIOABSORBABLE DERIVATIZED CHITOSAN COMPOSITIONS - The invention relates to biocompatible, bioabsorbable derivatized non-crosslinked chitosan compositions optionally crosslinked to gelatin/collagen by 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) for biomedical use and methods of making and testing such compositions, including a modified acute systemic toxicity test. The compositions comprise derivatized chitosan reacetylated to a degree of N-deacetylation (DDA) of between about 15% and 40%. The compositions are typically bioabsorbed in about 90 days or less and can be made to bioabsorb at differing rates of speed. The compositions are initially soluble in aqueous solution below pH 6.5. The compositions have an acid content that can be adjusted between about 0% (w/w) and about 8% (w/w) to customize the composition for uses that require and/or tolerate differing levels of cytotoxicity, adhesion, composition cohesion, and cell infiltration into the composition. | 09-18-2014 |
20140296354 | SYNTHESIS OF PEPTOID-BASED SMALL MOLECULAR GELATORS FROM MULTIPLE COMPONENT REACTIONS - Described herein are the one-pot synthesis and characterization of a library of low molecular weight peptoid compounds that are able to form gels at room temperature. The compounds are synthesized from biologically-based starting materials, are biocompatible, and are resistant to degradation by proteases and peptidases. The compounds and gels synthesized therefrom can be used in such applications as tissue engineering, drug delivery, separation of biomolecules, and stimulus-responsive advanced materials | 10-02-2014 |
20140364512 | COMPOSITIONS COMPRISING A COMBINATION OF AT LEAST ONE COLORANT AND AT LEAST ONE POLYSACCHARIDE - Dispersible colorants that include a combination of a colorant and a polysaccharide are provided, wherein the weight ratio of total colorant to total polysaccharide is in the range of 5000:1 to 1:5000. In one aspect, the colorant is a synthetic or natural colorant. In one aspect, polysaccharide is interpreted very broadly and provides a colored precipitate upon the combination of the colorant with the polysaccharide. | 12-11-2014 |
20140364513 | HIGHLY ROBUST FAST-DISINTEGRATING TABLET AND PROCESS FOR MANUFACTURING THE SAME - Disclosed are an oral formulation which disintegrates quickly in the oral cavity; a fast-disintegrating tablet having fast disintegrability and high hardness, and a process for manufacturing the same. In addition, slightly wetted granules for manufacturing said fast-disintegrating tablet and a process for manufacturing the same are disclosed. | 12-11-2014 |
20140378556 | FUCOSE-CONTAINING BACTERIAL BIOPOLYMER - The presently disclosed subject matter concerns a microbial biopolymer comprising fucose in its composition. This biopolymer consists of a polysaccharide comprising fucose, which represents at least 10% of its composition. This fucose-containing polysaccharide also contains non-sugar components, namely, acyl group substituents. This disclosed subject matter also concerns the process for the production of the biopolymer, which is obtained cultivation of the bacterium | 12-25-2014 |
20140378557 | Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans - Prolongation compositions for prolonging the presence of drugs in blood. | 12-25-2014 |
20150011660 | High-Purity Rubusoside And Process For Producing Of The Same - The invention provides a process of producing Rubusoside from steviol glycosides of Stevia rebaudiana plant. The process is useful for producing high purity Rubusoside with purity greater than 95% (dry basis). High purity rubusoside is useful as in combination with other caloric and non-caloric sweeteners as well as non-caloric sweetener in various food and beverage compositions. The high purity rubusoside is useful as non-caloric sweetener in edible and chewable compositions such as any beverages, confectionaries, bakeries, cookies, chewing gums, and alike. | 01-08-2015 |
20150018432 | Compositions and Methods Using Rebaudioside X to Provide Sweetness Enhancement - Sweetened compositions comprising at least one sweetener and rebaudioside X are provided herein. Rebaudioside X is present in the sweetened compositions in a concentration at or below the sweetness recognition threshold, while the at least one sweetener is present in a concentration above its sweetness recognition threshold. Rebaudioside X acts to enhance the sweetness of the sweetened compositions, e.g. beverages and concentrate compositions, thereby allowing for preparation of sweetened compositions with reduced calorie content. Methods of enhancing the sweetness of a sweetened composition with rebaudioside X are also provided herein. | 01-15-2015 |
20150018433 | FLUORINATED POLYMERIZABLE HYDROGELS FOR WOUND DRESSINGS AND METHODS OF MAKING SAME - Fluorinated hydrogels are used to dissolve oxygen or other oxygenated small molecules. The fluorinated hydrogels may release the dissolved oxygen or other oxygenated small molecules upon exposure to an environment of lower tension. The fluorinated hydrogels have a particular application in wound healing, where the fluorinated hydrogels may be used as a wound dressing. | 01-15-2015 |
20150025157 | NOVEL SUGAR-DERIVED GELATOR - There is provided a novel gelator containing a sugar derivative. A gelator including a compound of Formula (1) or Formula (2): | 01-22-2015 |
20150045453 | EMULSIFIED FOOD PRODUCT COMPOSITION - The purpose of the present invention is to provide an emulsified food product composition having good fluidity and emulsification stability, even when subjected to heat sterilization treatment, with which gastro-esophageal reflux can be prevented by gelling upon entering the stomach. By adding a gelling agent for gelling in the acidic region, at least one emulsion stabilizer selected from the group consisting of gum arabic and gum ghatti, and a divalent metal salt to the emulsified food product composition comprising a lipid, it is possible to realize the property of gelling upon entering the stomach and obtain good fluidity and emulsification stability, even if a heat sterilization treatment is used. | 02-12-2015 |
20150057371 | REVERSIBLE, ON-DEMAND GENERATION OF AQUEOUS TWO-PHASE MICRODROPLETS - The present invention provides methods of on-demand, reversible generation of aqueous two-phase microdroplets core-shell microbeads, microparticle preparations comprising the core-shell microbeads, and drug delivery formulation comprising the microparticle preparations. Because these aqueous microdroplets have volumes comparable to those of cells, they provide an approach to mimicking the dynamic microcompartmentation of biomaterial that naturally occurs within the cytoplasm of cells. Hence, the present methods generate femtoliter aqueous two-phase droplets within a microfluidic oil channel using gated pressure pulses to generate individual, stationary two-phase microdroplets with a well-defined time zero for carrying out controlled and sequential phase transformations over time. Reversible phase transitions between single-phase, two-phase, and core-shell microbead states are obtained via evaporation-induced dehydration and water rehydration. | 02-26-2015 |
20150057372 | Composition Having Stabilized Perfluorocarbons - An emulsion having stabilized perfluorocarbon(s) that includes an aqueous solution, an oil solution and a third phase which includes at least one perfluorocarbon and methods of making the stable perfluorocarbon containing emulsions. The aqueous and oil phases are first mixed together to form the emulsion. At least one perfluorocarbon is then added to the emulsion. Either the aqueous based solution or oil based solution may include at least one thickener. Moreover, the perfluorocarbon containing emulsion remains stable for a period of at least two weeks. | 02-26-2015 |
20150087725 | Injectable Gelling Material - A material is described herein. The material includes a multi-vinylsulfone containing molecule and a multi-nucleophile containing molecule. The material can form a hydrogel from an aqueous solution with dissolved multi-vinylsulfone and a multi-nucleophile. The aqueous solution can undergo gelation with a controllable gelation time to form the hydrogel upon administration to a space in a body. The hydrogel can form in situ with controllable properties, which allow the hydrogel to be used in many biomedical applications. Examples of biomedical applications include, but are not limited to, a volume/filler expander, a storage and delivery mechanism for biologics, and as a tissue interacting surface. | 03-26-2015 |
20150105478 | POLYELECTROLYTE COMPLEXES FOR BIOCIDE ENHANCEMENT - The invention relates to a composition comprising a polyelectrolyte complex of a polyanion and a polycation, and comprising at least one biocide. A preferred composition comprises lignosulfonate and chitosan, preferably in relative a amount of from 1:2 to 60:1 (w/w). The invention further relates to methods for generating a composition according to the invention, and to uses of a mixture according to the invention for protecting an agricultural plant or plant part against a pathogen. | 04-16-2015 |
20150126616 | Use Of N-Methyl-N-Acylglucamines As Thickening Agents In Surfactant Solutions - N-methyl-N-acylglucamines are suitable as thickening agents in aqueous surfactant solutions containing one or more anionic surfactants of the group including alkyl ether sulfates and alkyl sulfates, the N-methyl-N-acylglucamines containing at least 60 wt.-% of N-methyl-N-acylglucamines that have a C | 05-07-2015 |
20150126617 | SOLID AGAVE SYRUP COMPOSITIONS - The present invention relates to a agave syrup product having a low water content. The agave syrup product retains the physical and palatable properties of untreated agave syrup while having a prolonged shelf-life. It can be advantageously used to sweeten beverages (such as hot beverages) and in the manufacture of pharmaceutical compositions (such as throat lozenges) and/or confectionary. | 05-07-2015 |
20150126618 | COMPOSITION REPLACING WATER WITH HYALURONIC ACID AS THE PRIMARY INGREDIENT - A biologic formulation of 20% to 95% by weight of hyaluronic acid is provided such that the hyaluronic acid is the most common ingredient in the formulation. The formulation preferably also includes 0.1% to 1.5% by weight of a preservative, and a pH adjuster configured to provide a pH of less than 5.0 in the formulation. The hyaluronic acid is a combination of two or more different molecular weights of hyaluronic acid. The different molecular weights of hyaluronic acid are preferably cross-linked with glucosamine and ceramides. | 05-07-2015 |
20150289552 | INCREASING THE BIOAVAILABILITY OF FLAVAN-3-OLS WITH CARBOHYDRATES WITH A LOW GLYCEMIC INDEX - The present invention relates generally to the field of flavan-3-ols. In particular, the present invention provides a way to increase the bioavailability of flavan-3-ols. Embodiments of the present invention relate to the use of at least one carbohydrate with a glycemic index of less than 50 in a composition comprising at least one flavan-3-ol for increasing the bioavailability of said flavan-3-ol. | 10-15-2015 |
20150305381 | High-Purity Mogrosides And Process For Their Purification - The present invention provides a process for preparation of highly purified mogrosides mixture from low purity mogrosides mixture. The process comprises providing a mixture of low purity mogrosides, dissolving the low purity mogrosides mixture in water or an aqueous alcohol solution to form an initial solution of mogrosides, passing the initial solution through a column system, wherein the column system comprises a plurality of columns, and each column is packed with a sorbent having different affinities to impurities and mogrosides so that one or more columns retains more mogrosides than other columns, washing the columns to remove impurities with an acidic aqueous solution, a basic aqueous solution, and an aqueous alcoholic solution successively, eluting the columns with an aqueous alcohol solution that contains higher alcohol content than the aqueous alcohol solution used in the washing step, wherein the eluate from the columns with high content of mogrosides are combined, and drying the combined eluate to obtain high purity mogrosides with the content of the total mogrosides are more than 70% (w/w). The present invention also provides a sweetener mixture and product comprising high purity mogrosides. | 10-29-2015 |
20150322175 | LEGUME SEED POLYSACCHARIDE SUCCINIC ACID DERIVATIVE ESTER, AND METHOD FOR PRODUCING SAME - The object of the present invention is to provide a dispersion stabilizer that can minimize coagulated precipitation of a protein under acidic conditions, especially in the pH range of around pH 5 which is closer to neutrality than the range around the isoelectric point of the protein. It is possible to stabilize dispersion of protein particles around pH 5, and thus prepare an acidic protein food, by using a legume seed polysaccharide esterified with a succinic acid derivative having a hydrocarbon chain bonded to the 2-position carbon of succinic acid or succinic acid. The hydrocarbon chain of the succinic acid derivative preferably has 2 to 18 carbon atoms, and is most preferably an octenyl group. The esterified legume seed polysaccharides also have high emulsifying ability. | 11-12-2015 |
20150374622 | CHEWABLE COMPOSITION FOR ORAL ADMINISTRATION AND PROCESS FOR PREPARING THEREOF - The present invention relates to chewable compositions for oral administration, said compositions comprising high(methyl)pectin, glycerol and water. Advantageously, the chewable composition can comprise a drug substance. The present invention also concerns a process for preparing the chewable composition and the use of said chewable composition as a medicament. | 12-31-2015 |
20160021917 | SWEETENER - A low calorie sweetener composition with sweetness synergy, providing a reduction in off-taste and a desirable temporal profile. The sweetener composition comprises allulose, fructose and sucralose. In a preferred embodiment, the sweetener composition comprises allulose in an amount of at least about 45%, fructose in an amount of at least about 20%, and sucralose in an amount of at least about 0.01% by weight relative to the total weight of allulose, fructose and sucralose in the composition. The sweetener composition is suitable for use as a substitute for high calorie sugars. The sweetener composition is for use in food and beverage products, pharmaceutical products, nutritional product and cosmetic products. | 01-28-2016 |
20160058051 | HIGHLY SOLUBLE STEVIA SWEETENER - A method for making highly soluble | 03-03-2016 |
20160128371 | STEVIA EXTRACT CONTAINING SELECTED STEVIOL GLYCOSIDES AS FLAVOR, SALTY AND SWEETNESS PROFILE MODIFIER - Stevia extracts with selected major steviol glycosides (Reb A, stevioside, Reb D, Reb C) and minor steviol glycosides and glycosylated diterpene derivative plant molecules, derived from | 05-12-2016 |
20160130408 | METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS - The present invention relates to methods of processing lignocellulosic material to obtain hemicellulose sugars, cellulose sugars, lignin, cellulose and other high-value products such as asphalt and bio oils. Also provided are hemicellulose sugars, cellulose sugars, lignin, cellulose, and other high-value products such as asphalt and bio oils. | 05-12-2016 |
20160136080 | Colloidally Stable Dispersions Based on Modified Galactomannans - The disclosed technology relates to a multi-functional additive for personal-care and cosmetic product applications, more particularly, a naturally derived multifunctional additive for use in skin-care formulations, which provides steric stabilization of pigment particles and/or emulsion droplets in aqueous compositions, good suspension-stability (i.e., against settling/creaming) of the compositions, and increased utilization of particulate, skin-care benefit agents contained in the compositions. | 05-19-2016 |
20160151500 | METHOD FOR THE TREATMENT OF NANOHYDROGELS | 06-02-2016 |
20160175811 | POLYSACCHARIDE COMPOSITIONS FOR ABSORBING AQUEOUS LIQUID | 06-23-2016 |
20160198751 | SWEETENER COMPOSITIONS | 07-14-2016 |
20160375138 | CONSUMER GOODS PRODUCT COMPRISING FUNCTIONALISED LIGNIN OLIGOMER - The present invention relates to a consumer goods product comprising a consumer goods product ingredient and a functionalised lignin oligomer, wherein the functionalised lignin oligomer: (a) comprises less than 1 wt % sulphur content; (b) has a number average molecular weight ( | 12-29-2016 |
20170233500 | INACTIVATION OF OFF-TASTE INDUCING ENZYMES | 08-17-2017 |
20180021252 | INJECTABLE COMPOSITIONS | 01-25-2018 |
20180021437 | MICROSTRUCTURE USING CROSS-LINKED HYALURONIC ACID HYDROGEL, AND METHOD FOR PRODUCING SAME | 01-25-2018 |